Lilly’s Early Bird Verzenio Goes After Up To S4bn Worm With Early Breast Cancer Nod

 
• By Alaric DeArment
  
Doctor with Mammography - Image
The FDA approved Lilly's Verzenio for certain early-stage HR+/HER2- breast cancer patients • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from New Products

More from Scrip